EGFR mutation unique to glioblastoma linked to lack of response
13 Apr 2012
EGFR mutation unique to glioblastoma linked to lack of response
Use of neutrophils to prevent lung metastases in breast cancer patients
Antiangiogenic therapies for non-small cell lung cancer
Cellular pathways in lung cancer and the need for personalised medicine
The evolving role of immunotherapy in oncology
Latest in renal carcinoma
Use of circulating tumour cells as a prognostic or predictive marker
Advances in the treatment of lung cancer and melanoma
Message from the President-Elect of ESTRO
Roundup of the EMCC 2011 conference
Development of a lung cancer blood test
Future for immunotherapies